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ABSTRACT Enterococcus faecium is a leading cause of health care-associated infec-
tions, with speciﬁc lineages circulating in hospital settings worldwide. Here, we re-
port the draft genome sequence of the multidrug-resistant and bioﬁlm-producing E.
faecium UEL170, sequence type 412 (ST412), isolated from an inpatient with a uri-
nary tract infection. This strain is a member of clonal complex 17 (CC17), a globally
hospital-associated clone.
Enterococcus faecium can be found as a harmless colonizer of the gastrointestinaltract of humans and animals. However, as an opportunistic pathogen, this bacte-
rium is an important causative agent of health care-associated infections (HAI) world-
wide (1–3). This scenario may be associated with E. faecium’s remarkable capacity to
acquire resistance to many antimicrobials and the extraordinary plasticity of its ge-
nome, which contributes to bacterial adaptation in different environments (4, 5).
Molecular epidemiological studies revealed the existence of speciﬁc genogroups, in-
cluding a hospital-associated E. faecium subpopulation, collectively known as clonal
complex 17 (CC17) (6, 7). This clonal complex has been widely detected in hospital
settings around the world (7, 8), including in Brazil (2, 9–11). In particular, the
multidrug-resistant E. faecium sequence type 412 (ST412) that belongs to CC17 has
been disseminated in various Brazilian hospitals (9–11).
University Hospital of Londrina (UHL) is a teaching hospital and a major referral
center in the north of Paraná, Brazil, for the Sistema Único de Saúde, a government
public health system. In this institution, vancomycin-resistant enterococci (VRE) that
were detected in surveillance rectal swab cultures from patients housed in intensive
care units were ﬁrst reported in 2002; the ﬁrst outbreak of VRE (predominantly E.
faecium [VREfm]) occurred in 2005 (12), and it remains among the leading Gram-
positive bacteria isolated from HAI (13). Here, we describe the draft genome of the
VREfm UEL170 strain, which was isolated from an inpatient with a urinary tract infection
in 2007. This strain is phenotypically resistant to ampicillin, ciproﬂoxacin, erythromycin,
streptomycin, tetracycline, teicoplanin, and vancomycin (1); it is a strong bioﬁlm-
producing bacterium on abiotic surfaces (1), and it belongs to ST412 (14).
For DNA isolation, 5 CFU was inoculated into brain heart infusion (BHI) broth
(HiMedia, Brazil), and the culture was incubated for 24 h at 37°C. The cells were
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harvested by centrifugation (2,600  g for 10 min at 10°C) and washed twice with 0.15
phosphate-saline buffer at pH 7.2. Genomic DNA was extracted using the DNeasy blood
and tissue kit (Qiagen, Germany) according to the manufacturer’s standard protocols
and processed on a MiSeq platform using a MiSeq reagent v3 kit (600 cycles; Illumina,
Brazil) at Embrapa Soja in Londrina, Brazil. Shotgun sequencing with the paired-end
sequence strategy allowed a genome coverage of approximately 550-fold, which
resulted in a total of 6,422,034 reads (300 bp each). The genome was assembled by the
de novo strategy using the A5-miseq assembly pipeline. The data were ﬁltered and
trimmed to a Phred score of 20 using the quality assessment tool for genome
assemblies (QUAST [http://quast.sf.net]) according to the default software recommen-
dations (15), generating 227 contigs. The genome was annotated with Rapid Annota-
tion using System Technology (RAST) v2.0 (http://rast.nmpdr.org) using FIGfams tech-
nology release 70 according to the default software recommendations (16). Assembly
of the genome generated a total size of 3,040,378 bp and a mean GC content of 38%
with N50 and L50 values of 37,880 bp and 24 bp, respectively. The following acquired
antimicrobial resistance and virulence genes were identiﬁed by ResFinder v3.0 (17)
and VirulenceFinder (18), respectively (http://cge.cbs.dtu.dk/services): aph(3=)-III and
ant(6)-Ia (aminoglycoside resistance), erm(B) (macrolide resistance), msr(C) (macrolide,
lincosamide, and streptogramin B resistance), vanA (glycopeptide resistance), acm
(collagen-binding adhesin of microbial surface components recognizing adhesive ma-
trix molecule [MSCRAMM] family), efaAfm (endocarditis-speciﬁc antigen A adhesin), and
espfm (enterococcal surface protein). The availability of this genome sequence may
help in exploring new targets for antimicrobial agents, including those exhibiting
antibioﬁlm activity against VREfm.
Data availability. A data ﬁle containing the raw reads was uploaded to the NCBI
Sequence Read Archive (accession number SRR8362446). The whole-genome shot-
gun sequence of VREfm UEL170 was deposited at DDBJ/ENA/GenBank under the
accession number RBBX00000000 (BioProject number PRJNA493784, BioSample num-
ber SAMN10142019). The version described here is the ﬁrst version.
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